Pushing technology and drugs to the limit in efforts to deal with dementia | Letters
The Guardian - Pharmaceutical Industry
MAY 3, 2023
Indeed, Alzheimer’s Society first funded Prof John Hardy’s amyloid research back in 1989, and it is only now that we are seeing the first amyloid-targeting treatments that show evidence of slowing the progression of Alzheimer’s disease. Continue reading.
Let's personalize your content